Sab Biotherapeutics Inc WT (SABSW)
Sab Biotherapeutics Inc WT (SABSW)
0.1474 +0.0674 (+84.25%) 01/16/25 [NASDAQ]
0.0041 x 120,000 0.1474 x 300
Realtime by (Cboe BZX)
0.0041 x 120,000 0.1474 x 300
Realtime - - (-) -
for Thu, Jan 16th, 2025
Results
download Want to compare other data? Select FieldsSymbol | SABSW | PBM | BDRX | ||
Company | Sab Biotherapeutics Inc WT | Psyence Biomedical Ltd | Biodexa Pharmaceuticals Plc ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.1474 | 1.6100 | 4.31 | ||
High | 0.1474 | 1.8200 | 4.35 | ||
Low | 0.1474 | 1.6100 | 4.27 | ||
Last | 0.1474 | 1.7700 | 4.34 | ||
Change | +0.0674 | +0.1300 | +0.18 | ||
% Change | +84.25% | +7.93% | +4.33% | ||
Volume | 200 | 183,000 | 9,300 | ||
20-Day Average Volume | 25,130 | 5,402,700 | 16,955 | ||
Previous Close | 0.0800 | 1.6400 | 4.16 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.0873 | 2.0665 | 4.22 | ||
20-Day Raw Stochastic | 97.67% | 4.09% | 58.06% | ||
20-Day Relative Strength | 59.49% | 36.24% | 46.07% | ||
Weighted Alpha | +10.54 | -98.57 | -88.39 | ||
Today's Opinion | 100% Buy | 100% Sell | 88% Sell | ||
Previous Opinion | 88% Buy | 100% Sell | 100% Sell | ||
Last Month's Opinion | 64% Buy | 100% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +10.91% since 01/08/25 | -3.80% since 01/08/25 | +1.64% since 01/08/25 | ||
Low | 0.0800 on 01/15/25 | 1.6100 on 01/16/25 | 4.13 on 01/14/25 | ||
High | 0.1474 on 01/16/25 | 2.2500 on 01/13/25 | 4.60 on 01/13/25 | ||
1-Month | |||||
%Chg | +189.02% since 12/16/24 | -4.32% since 12/16/24 | +4.58% since 12/16/24 | ||
Low | 0.0383 on 12/18/24 | 1.5100 on 12/18/24 | 3.80 on 12/23/24 | ||
High | 0.1500 on 01/08/25 | 7.8700 on 12/19/24 | 4.73 on 12/26/24 | ||
3-Month | |||||
%Chg | +227.56% since 10/16/24 | -78.55% since 10/16/24 | -48.33% since 10/16/24 | ||
Low | 0.0383 on 12/18/24 | 1.5100 on 12/18/24 | 3.50 on 11/19/24 | ||
High | 0.1500 on 01/08/25 | 10.3500 on 10/22/24 | 7.47 on 11/21/24 | ||
6-Month | |||||
%Chg | +284.86% since 07/12/24 | -94.62% since 07/16/24 | -82.45% since 07/16/24 | ||
Low | 0.0179 on 09/20/24 | 1.5100 on 12/18/24 | 3.50 on 11/19/24 | ||
High | 0.1500 on 01/08/25 | 87.7275 on 07/25/24 | 25.50 on 07/17/24 | ||
Key Statistics | |||||
Market Capitalization, $K | N/A | 1,492 | 516 | ||
Shares Outstanding, K | N/A | 843 | 119 | ||
Annual Sales | 2,240,000 | 0 | 410,000 | ||
Annual Net Income | -42,190,000 | -51,160,000 | -7,660,000 | ||
Last Quarter Sales | 0 | 0 | N/A | ||
Last Quarter Net Income | -10,349,410 | -314,031 | N/A | ||
60-Month Beta | N/A | -0.45 | 1.46 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | N/A on 01/31/24 | N/A | ||
Latest Earnings Date | 11/11/24 | 05/04/16 | 04/26/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | N/A | 0.00 | 0.00 |